 AMAG Pharmaceuticals, Inc. NASDAQ:AMAG Stock analysts at Piper Sandler dropped their Q1 2020 EPS estimates for AMAG Pharmaceuticals in a research report issued on Tuesday, April 14th. Piper Sandler analyst C. Raymond now forecasts that the specialty pharmaceutical company will post earnings per share of 0.23 for the quarter, down from their previous estimate ... 